AC IMMUNE SA SF-02 (IMR) — Cash Flow Reinvestment Rate
AC IMMUNE SA SF-02 (IMR) has a Cash Flow Reinvestment Rate of 0.64x as of December 2024, reinvesting €3.83 Million (capex €90.00K plus investments €-3.74 Million) from operating cash flow of €5.93 Million. Check AC IMMUNE SA SF-02 cash earnings quality to evaluate the quality of earnings relative to operating cash generation.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
AC IMMUNE SA SF-02 Cash Flow Reinvestment Rate (2024–2024)
Historical reinvestment intensity for AC IMMUNE SA SF-02 across 1 annual periods. Explore IMR strategic capital deployment ratio to see how much of total assets are deployed in long-term investments.
Annual Cash Flow Reinvestment Rate for AC IMMUNE SA SF-02 (2024–2024)
Year-by-year capital reinvestment analysis for AC IMMUNE SA SF-02. For live market cap and broader valuation context, see IMR company net worth.
| Year | Reinvestment Rate | Total Reinvested (EUR) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2024 | 1.60x | €105.24 Million | €65.84 Million | €576.00K | — |